Article

Study: Vitamin D Intake Doesn't Matter in Liver Chemistry

Author(s):

Many studies have looked at the link between vitamin D deficiency and liver disease. A Korean team recently examined whether vitamin D deficiency played a pivotal role in abnormal liver enzymes.

Deficiency in vitamin D has been shown to be associated with a higher prevalence of liver disease and with liver disease progressing more rapidly. But it is not clear if vitamin D intake plays a pivotal role in having a deficiency serum vitamin D and/or abnormal liver enzymes.

In a study reported April 23 at the 2015 International Liver Congress in Vienna, Austria, a South Korean team presented its findings using data from the Korean National Health and Nutrition Examinations. A total of 27,463 people participated and data covered the years 2008 through 2011.

Vitamin D deficiency was defined as levels below 20 ng/ml of 25-OH-vitamin D.

Ho Hyan Nam, of the Department of Internal Medicine, Hanyang University in Seoul led the study.

With colleagues, Nam found that serum vitamin D levels had a positive correlation with body mass index, fasting glucose, and aminotransferase activity.

Both vitamin D intake and whether subjects lived in rural or urban areas were found to be independent risk factors.

The total amount of vitamin D uptake was lower in those who lived in rural areas and was also lower in blue-collar workers than in those who lived in urban areas and had white-collar jobs. Serum vitamin D was also higher in subjects from rural areas.

The amount of vitamin D intake did not show any correlation with aminotransferase activity or metabolic parameters, they found.

Vitamin D deficiency, not vitamin D intake was an independent risk factor for abnormal liver enzyme only in obese and blue-collar subjects, they reported.

Their conclusions: "Vitamin D deficiency was a risk factor of elevated aminotransferase level and prevalence of metabolic syndrome in obesity," but, they added, the amount of vitamin D intake did not show any association with metabolic parameters or liver chemistry.

Related Videos
Achieving Quick Responses in Sickle Cell Anemia With Early, Appropriate Hydroxyurea Dosing, with Abena Appiah-Kubi, MD, MPH
Steven W. Pipe, MD: Fitusiran With Anti-Thrombin Modulation Yields Effective Bleed Control, Reduces Infusions
Caroline Piatek, MD: Improving Patient-Reported Outcomes in PNH With Danicopan Add-on Therapy
Haydar Frangoul, MD: Preventing VOCs in People With Sickle Cell Disease With Exa-Cel Gene Editing Therapy
Jörn Schattenberg, MD | Credit: Novo Nordisk
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
Jörn Schattenberg, MD | Credit: Novo Nordisk
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
© 2024 MJH Life Sciences

All rights reserved.